<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14736">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02915055</url>
  </required_header>
  <id_info>
    <org_study_id>16-01645</org_study_id>
    <nct_id>NCT02915055</nct_id>
  </id_info>
  <brief_title>NSAID vs. Narcotics</brief_title>
  <official_title>Multimodal Analgesia With NSAID vs. Narcotics Alone for Post-operative Meniscectomy: A Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a single-center, prospective observational study. The study will compare
      post-operative pain scores and narcotic consumption between two groups of patients - one
      cohort will receive ibuprofen (Motrin) and Percocet (to be used as needed) while the other
      cohort will receive only Percocet. Both pain management options are considered to be
      standard of care.

      The primary objective of the study is to compare patients' reported pain and narcotic use
      following meniscectomy, and determine if NSAIDs can provide adequate pain relief.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue scale (VAS) score</measure>
    <time_frame>4 Hours</time_frame>
    <description>Scale consisting of a drawn line from 0 to 100 - you will be asked to mark where you believe your pain is (100 being worse pain).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Verbal Rating Scale</measure>
    <time_frame>4 Hours</time_frame>
    <description>Verbal rating scale, consisting of 4 points (0 = no pain, 1 = mild, 2 = moderate, and 3 = severe).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Multimodal Analgesia</condition>
  <condition>Nonsteroidal Anti-inflammatory Drugs</condition>
  <arm_group>
    <arm_group_label>Patients with pain following knee arthroscopic meniscectomy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen 600 mg</intervention_name>
    <description>Ibuprofen 600 mg to be taken every 8 hours (TID) as needed (PRN</description>
    <arm_group_label>Patients with pain following knee arthroscopic meniscectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard oxycodone/acetaminophen</intervention_name>
    <arm_group_label>Patients with pain following knee arthroscopic meniscectomy</arm_group_label>
    <other_name>Percocet</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients indicated for isolated arthroscopic meniscectomy will be identified from the
        operating room schedules of orthopaedic surgeons participating in the study. And a review
        of patients' medications and past medical histories will be performed based on their
        electronic medical records to identify any current pain medications or exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be at least 18 years of age

          -  ASA class I-II

          -  Patients scheduled for meniscectomy

        Exclusion Criteria:

          -  Contraindication to ibuprofen or oxycodone/acetaminophen (e.g. hypersensitivity,
             history of GI or bleeding disorder)

          -  Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects,
             dementia, etc.)

          -  Younger than 18 years of age or older than 65

          -  Any patient considered a vulnerable subject

          -  Patients on pain medication prior to surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kirk Campbell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hien Pham, MD</last_name>
    <email>Hien.Pham@nyumc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hien Pham, MD</last_name>
      <email>Hien.Pham@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Kirk Campbell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 22, 2016</lastchanged_date>
  <firstreceived_date>September 22, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Analgesic efficacy</keyword>
  <keyword>knee arthroplasty</keyword>
  <keyword>Opioid consumption</keyword>
  <keyword>Pain Medicine</keyword>
  <keyword>Narcotics</keyword>
  <keyword>Multimodal Analgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen, hydrocodone drug combination</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Narcotics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
